Money: Scientists from Wroclaw are working on breakthrough drugs for dogs, horses and cats. They are being supported by experienced investors. The objective is clear: Bioceltix wants to become one of the first companies in the world to register it’s stem-cell-based biopharmaceutical with the European Medicines Agency (EMA).
– the market for veterinary biopharmaceuticals is still in its early stages of development. It was just 2 two years ago that the first biopharmaceutical drug in EMA history was registered. We’re looking to change the current state of the market, says Bioceltix CEO, Łukasz Bzdzion. Find out more about what Bioceltix has in store.
Puls Biznesu about our plans: Bioceltix announces that it will soon debut on NewConnect – the company has recently completed the pre-IPO round. So far, the company has obtained a total of approx. PLN 20 million in financing for the development of a still innovative method of treating pets ...
ArticleForbes about Polish start-ups in the coronavirus crisis: “The year 2020 was a big challenge for companies, individual sectors of the economy and probably all of us. In the coming weeks and months of 2021 it will be similar. The condition of start-ups is no exception here. it is easier and ...
ArticleAccording to the „Investors’ Zone”, an interesting year is being prepared on the stock exchange: “This year, an exceptionally large group of companies is choosing NewConnect. As many as 63 companies declared their willingness to enter the alternative market, and several more in the ...
ArticleGazeta Wrocławska wrote about us: “Bioceltix is working on innovative biological medicines used in the treatment of common autoimmune and inflammatory diseases in companion animals. The company from Wrocław has something to fight for. This is indicated by the numbers on the global drug ...
ArticleWe create at Bioceltix veterinary biological medicines, and in 2020 we announced plans for a stock exchange debut and we obtained a permit from the Main Pharmaceutical Inspector to manufacture veterinary biological drugs. Despite the pandemic, we continue our projects without downtime. You can ...
ArticleMany biotech startups are spending money from investors and grants by the billions, in an effort to find new ways of treating humans, but some of ...
Read fullWe have found ourselves in the ranking of the 5 most promising Polish start-ups prepared by Money.pl! “From those looking for a drug to cure ...
Read fullŁukasz Bzdzion visited Filip Marczyński on Radio Wrocław. The CEO of Bioceltix talked about biological drugs for animals that are currently ...
Read full
